Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- A4313 Cobicistat (GS-9350)Target: Cytochrome P450 (CYP450)Summary: Selective CYP3A inhibitor
- A4316 KetoconazoleTarget: Cytochrome P450 (CYP450)Summary: Inhibitor of cyclosporine oxidase and testosterone 6 beta-hydroxylase
- A4317 Apremilast (CC-10004)Target: Phosphodiesterases (PDEs)Summary: PDE4 inhibitor
- A4318 AvasimibeTarget: Acyl coenzyme A: cholesterol acyltransferasesSummary: ACAT inhibitor,orally bioavailable
- A4323 Vardenafil HCl TrihydrateTarget: Phosphodiesterases (PDEs)Summary: PDE5 inhibitor, potent and selective
- A4324 Pioglitazone HClSummary: PPARγ agonist
- A4325 PF-2545920Target: Phosphodiesterases (PDEs)Summary: PDE10A inhibitor,potent and selective
- A4327 TadalafilTarget: Phosphodiesterases (PDEs)Summary: PDE5 inhibitor
- A4330 IsotretinoinTarget: RARsSummary: Dopamine β-hydroxylase activator
- A4332 Nepicastat (SYN-117) HClSummary: Dopamine-β-hydroxylase inhibitor